The diabetic CKD patient--a major cardiovascular challenge
Related Experiment Video
Updated: Jun 11, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Irene M van der Meer1, Piero Ruggenenti, Giuseppe Remuzzi
1Unit of Nephrology, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy. imvandermeer23@hotmail.com
Insights
Diabetic patients with chronic kidney disease (CKD) face high cardiovascular disease (CVD) risk. Tailored prevention strategies addressing CKD-specific factors are crucial, as standard treatments may not apply to advanced renal disease patients.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Diabetic patients with chronic kidney disease (CKD) exhibit a significantly elevated risk of cardiovascular disease (CVD).
- Effective primary and secondary CVD prevention strategies are essential for this high-risk population.
- CKD-specific risk factors, including albuminuria, anemia, and CKD-mineral and bone disorder, require targeted management alongside traditional cardiovascular risk factors.
Purpose of the Study:
- To highlight the complexities in managing cardiovascular disease risk in diabetic patients with chronic kidney disease.
- To emphasize the limitations of current treatment guidelines derived from general populations for patients with advanced renal disease or on renal replacement therapy.
- To advocate for an individualized treatment approach for this specific patient group.
Main Methods:
- Review of existing literature and clinical guidelines concerning cardiovascular risk in diabetic CKD patients.
- Analysis of the applicability of traditional cardiovascular risk factor management in advanced CKD and renal replacement therapy populations.
- Discussion of CKD-specific risk factors and their impact on CVD.
Main Results:
- Standard cardiovascular treatment goals and interventions may not be suitable or effective for patients with advanced CKD.
- In patients undergoing renal replacement therapy, the relationship between traditional CVD risk factors and CVD incidence can be inverted.
- Pharmaceutical interventions proven beneficial in the general population might be ineffective or detrimental in advanced CKD patients.
Conclusions:
- Healthcare providers must recognize the unique challenges in managing CVD risk in diabetic patients with CKD.
- An individualized approach to treatment, considering both traditional and CKD-specific factors, is imperative.
- Further research is needed to establish evidence-based guidelines for CVD prevention in advanced renal disease.
Abstract:
The diabetic patient with chronic kidney disease (CKD) is at very high risk of cardiovascular disease (CVD). Primary and secondary CVD prevention is of major importance and should be targeted at both traditional cardiovascular risk factors and risk factors specific for patients with CKD, such as albuminuria, anaemia and CKD--mineral and bone disorder. However, treatment goals have largely been derived from clinical trials including patients with no or only mild CKD and may not be generalizable to patients with advanced renal disease. Moreover, in patients on renal replacement therapy, the association between traditional CVD risk factors and the incidence of CVD may be reversed, and pharmaceutical interventions that are beneficial in the general population may be ineffective or even harmful in this high-risk population. Those involved in the delivery of care to patients with diabetes and CKD need to be aware of these issues and should adopt an individualised approach to treatment.
Related Concept Videos
01:28Diabetic Nephropathy
01:24Chronic Kidney Disease II: Clinical Manifestations
01:25Chronic Kidney Disease I: Introduction
01:18Chronic Kidney Disease IV: Nursing Management
01:28Chronic Kidney Disease III: Interprofessional Care
01:22Complications of Diabetes Mellitus